In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics

Diagnostic Microbiology and Infectious Disease

Volumn 49, Issue 3, 2004, Pages 197-200

  Giacometti, Andrea ^a   Cirioni, Oscar ^a   Kamysz, Wojciech ^b   D'Amato, Giuseppina ^a   Silvestri, Carmela ^a   Del Prete, Maria Simona ^a   Lukasiak, Jerzy ^b   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CECROPIN A; CIPROFLOXACIN; CLARITHROMYCIN; IMIPENEM; RIFAMPICIN; SYNTHETIC PEPTIDE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HOSPITAL INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; CROSS INFECTION; DRUG INTERACTIONS; FEMALE; HUMANS; IMIPENEM; MALE; MELITTEN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 3042758514     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.02.008     Document Type: Article

References (18)

1. Andreu D., Ubach J., Boman A., Wåhlin B., Wade D., Merrifield R.B., Boman H.G. Shortened cecropin A-mellitin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett. 296:1992;190-194
2. Cannon M. A family of wound healers. Nature. 328:1987;478
3. Cormican M.G., Jones R.N. Emerging resistance to antimicrobial agents in Gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococci. Drugs. 51:1996;S6-S12
4. Eliopoulos G.M., Moellering R.C. Jr. Antimicrobial combinations. Loria V. Antibiotics in Laboratory Medicine. 1991;432-444 Williams & Wilkins, Baltimore, Md
5. Hancock R.E.W. Peptides antibiotics. Lancet. 349:1997;418-422
6. Hancock R.E.W., Chapple D.S. Peptide antibiotics. Antimicrob Agents Chemother. 43:1999;1317-1323
7. Hancock R.E.W. Cationic antimicrobial peptides Towards clinical applications. Exp Opin Invest Drugs. 9:2000;1723-1729
8. Hultmark D., Steiner H., Rasmuson T., Boman H.G. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur J Biochem. 106:1980;7-16
9. Jack R.W., Tagg J.R., Ray B. Bacteriocins of Gram-positive bacteria. Microbiol Rev. 59:1995;171-200
10. Kamysz W., Kochańska B., Kȩdzia A., Ochocińska J., Maćkiewicz Z., Kupryszewski G. Statherin SV2 and its analogue. Synthesis and evaluation of antimicrobial activity. Polish J Chem. 76:2002;801-806
11. Labischinski H., Ehlert K., Berger-Bächi B. The targeting of factors necessary for expression of methicillin resistance in staphylococci. J Antimicrob Chemother. 41:1998;581-584
12. Merrifield R.B., Juvvadi P., Andreu D., Ubach J., Boman A., Boman H.G. Retro and retroenantio analogs of cecropin-melittin hybrids. Proc Natl Acad Sci U S A. 92:1995;3449-3453
13. Moore A.J., Beazley W.D., Bibby M.C., Devine D.A. Antimicrobial activity of cecropins. J Antimicrob Chemother. 37:1996;1077-1089
14. National Committee for Clinical Laboratory Standards (2003). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard M7-A6. Villanova, PA
15. Oh H., Hedberg M., Wade D., Edlund C. Activities of synthetic hybrid peptides against anaerobic bacteria Aspects methodology and stability. Antimicrob Agents Chemother. 44:2000;68-72
16. Sahl H.G., Jack R.W., Bierbaum G. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur J Biochem. 230:1995;827-853
17. Saugar J.M., Alarcon T., Lopez-Hernandez S., Lopez-Brea M., Andreu D., Rivas L. Activity of polymyxin B and cecropinA-melittin peptide CA(1-8)M(1-18) against a multireistant strain of Acinetobacter baumannii. Antimicrob Agents Chemother. 46:2000;875-878
18. Wade D., Andreu D., Mitchell S.A., Silveira A.M., Boman A., Boman H.G., Merrifield R.B. Antibacterial peptides designed as analogs or hybrids of cecropins and mellitin. Int J Pept Protein Res. 40:1992;429-436